Linked videos:
• Why finasteride stops ...
• The truth about dutast...
• Using finasteride and ...
• What is the perfect do...
• What is the optimal do...
Sources:
1. Lee WS, Ro BI, Hong SP, et al. A new classification of pattern hair loss that is universal for men and women: Basic and specific (BASP) classification. Journal of the American Academy of Dermatology. 2007;57(1):37-46. doi:10.1016/j.jaad.2006.12.029
2. Andriole Gerald L., Bostwick David G., Brawley Otis W., et al. Effect of Dutasteride on the Risk of Prostate Cancer. New England Journal of Medicine. 2010;362(13):1192-1202. doi:10.1056/NEJMoa0908127
3. Rossi A, Cantisani C, SCARNò M, Trucchia A, Fortuna MC, Calvieri S. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up: Finasteride 10 year follow-up. Dermatologic Therapy. 2011;24(4):455-461. doi:10.1111/j.1529-8019.2011.01441.x
4. Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. 2014;70(3):489-498.e3. doi:10.1016/j.jaad.2013.10.049
5. Jung JY, Yeon JH, Choi JW, et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatol. 2014;53(11):1351-1357. doi:10.1111/ijd.12060
6. Yoshitake T, Takeda A, Ohki K, et al. Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. The Journal of Dermatology. 2015;42(7):735-738.
7. Tsunemi Y, Irisawa R, Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology. 2016;43(9):1051-1058. doi:10.1111/1346-8138.13310
8. Shin J, Chung E, Kim M, Kim T, Kim W, Huh C. Evaluation of long‐term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system. J Dermatol. 2019;46(2):139-143. doi:10.1111/1346-8138.14719
9. Yanagisawa M, Fujimaki H, Takeda A, Nemoto M, Sugimoto T, Sato A. Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia. Clin Res Trial. 2019;5(5). doi:10.15761/CRT.1000273
10. Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging. 2019;14:399-406. doi:10.2147/CIA.S192435
11. Choi GS, Sim WY, Kang H, et al. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. Ann Dermatol. 2022;34(5):349. doi:10.5021/ad.22.027
12. Lim JH, Choi SM, Kwon SH, Sim WY, Lew BL. 42889 Long-term efficacy and safety of dutasteride in Korean men with androgenetic alopecia: 5-year follow-up data exhibiting clinical improvement with sustained efficacy. Journal of the American Academy of Dermatology. 2023;89(3):AB189. doi:10.1016/j.jaad.2023.07.757
13. Choi S, Kwon SH, Sim WY, Lew BL. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. J Dermatol. 2024;51(5):684-690. doi:10.1111/1346-8138.17138
Негізгі бет Тәжірибелік нұсқаулар және стиль Why dutasteride stops hair loss forever
Пікірлер: 1 М.